Results 121 to 130 of about 18,346 (199)

Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models.

Blood
Miao H, Wu T, Purohit T, Chen D, Klossowski S, Borkin D, Clegg B, Ray J, Park S, Stevens R, Kim E, Kempinska K, Wang Y, He M, Wen B, Goldman JW, Agrusa J, Ding C, Sulis ML, Sun D, Mody R, Kim AS, Ren P, Li LS, Liu Y, Burrows F, Kessler L, Cierpicki T, Grembecka J.   +28 more
europepmc   +1 more source

A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations. [PDF]

Cancers (Basel)
Ayerbe C, Fan AE, Scanlan R, Raj R, Catueno S, Ray A, Aguirre H, McCall D, Roth M, Garcia MB, Nunez C, Sheikh IN, Garcia-Manero G, Cuglievan B, Gibson A.   +14 more
europepmc   +1 more source

Anti-inflammatory approaches in cancer immunotherapy-induced autoimmunity. [PDF]

EULAR Rheumatol Open
Zeiser R.
europepmc   +1 more source

Minimally Invasive Surgical Resolution of Omental Infarction: A Case of Refractory Abdominal Pain. [PDF]

Cureus
Wosiack Menin AI, Romagnoli Razmilic M, Wosiack Menin L, Caballero R.   +3 more
europepmc   +1 more source

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors. [PDF]

Blood Cancer J
Shukla N, Charalambous K, Li S, Ko KH, Casanova H, Buehler E, Cobbs C, Patel R, Brannon AR, Ewalt MD, Sulis ML, Carroll WL, Arcila ME, Mohibullah N, Berger M, Levine RL, Stein EM, Shah R, Cai SF.   +18 more
europepmc   +1 more source

FLT3-mutated AML: standards of care and ongoing investigation. [PDF]

Blood Res
Do LV, Jorgensen JJ, Sahasrabudhe KD.
europepmc   +1 more source

Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments. [PDF]

Cancers (Basel)
Testa U, Pelosi E, Castelli G.
europepmc   +1 more source

Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting. [PDF]

Exp Hematol Oncol
Yu H, Shi T, Zhu HH.
europepmc   +1 more source

Menin: Expanding and dichotomous roles in cancer

Oncoscience, 2019
Katona, Bryson W., Glynn, Rebecca A., Hojnacki, Taylor A., Hua, Xianxin   +3 more
openaire   +2 more sources

Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL-Fusion Leukemia. [PDF]

Cancer Sci
Li A, Zhang Y, Li Z, Liu A, Zhang L, Gao S, Lin X, Liu X, Li H, Jin G, Xu B.   +10 more
europepmc   +1 more source